nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alternative Complement Pathway Signature Determines Immunosuppression and Resistance to Immunotherapy Plus Tyrosine Kinase Inhibitor Combinations in Renal Cell Carcinoma
|
Wang, Jiajun |
|
|
41 |
1 |
p. 51.e13-51.e23 |
artikel |
2 |
A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy
|
Gross, Evan E. |
|
|
41 |
1 |
p. 51.e25-51.e31 |
artikel |
3 |
A population-based evaluation of tunica vaginalis mesothelioma: An analysis of the National Cancer Database
|
Witmer, Hunter D.D. |
|
|
41 |
1 |
p. 52.e11-52.e20 |
artikel |
4 |
Assessing extra-prostatic extension for surgical guidance in prostate cancer: Comparing two PSMA-PET tracers with the standard-of-care
|
Bahler, Clinton D. |
|
|
41 |
1 |
p. 48.e1-48.e9 |
artikel |
5 |
Can microRNAs be utilized as tumor markers for recurrence following nephrectomy in renal cell carcinoma patients? A meta-analysis provides the answer
|
Aalami, Amir Hossein |
|
|
41 |
1 |
p. 52.e1-52.e10 |
artikel |
6 |
Cover 2 - Masthead
|
|
|
|
41 |
1 |
p. IFC |
artikel |
7 |
Impact of choosing wisely on imaging in men with newly diagnosed prostate cancer
|
Lange, Suzanne M. |
|
|
41 |
1 |
p. 48.e19-48.e26 |
artikel |
8 |
Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy
|
Claps, Francesco |
|
|
41 |
1 |
p. 49.e13-49.e22 |
artikel |
9 |
Inguinal lymph node dissection in the era of minimally invasive surgical technology
|
Nabavizadeh, Reza |
|
|
41 |
1 |
p. 1-14 |
artikel |
10 |
Nephrometric scoring system: Recent advances and outlooks
|
Xiao, Yu |
|
|
41 |
1 |
p. 15-26 |
artikel |
11 |
Nephrometry and cumulative morbidity after partial nephrectomy: A standardized assessment of complications in the context of PADUA and R.E.N.A.L. scores
|
Filipas, Dejan K. |
|
|
41 |
1 |
p. 51.e1-51.e11 |
artikel |
12 |
Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma
|
Midenberg, Eric |
|
|
41 |
1 |
p. 50.e19-50.e26 |
artikel |
13 |
5α-reductase inhibitors and the risk of bladder cancer in a large, population-based cohort
|
Dekalo, Snir |
|
|
41 |
1 |
p. 50.e11-50.e17 |
artikel |
14 |
Systemic therapy in bladder preservation
|
Girardi, Daniel M. |
|
|
41 |
1 |
p. 39-47 |
artikel |
15 |
Systemic therapy issues: Immunotherapy in nonmetastatic urothelial cancer
|
Nadal, Rosa |
|
|
41 |
1 |
p. 27-34 |
artikel |
16 |
Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer
|
Ballas, Leslie |
|
|
41 |
1 |
p. 35-38 |
artikel |
17 |
The rising incidence of ductal adenocarcinoma and intraductal carcinoma of the prostate: Diagnostic accuracy of biopsy, MRI-visibility, and outcomes
|
Pahouja, Gaurav |
|
|
41 |
1 |
p. 48.e11-48.e18 |
artikel |
18 |
Treatment options and prognostic risk factors for urachal carcinoma: A multicetnter retrospective study
|
Ke, Chunjin |
|
|
41 |
1 |
p. 50.e1-50.e9 |
artikel |
19 |
Value of multiparametric magnetic resonance imaging for local staging of invasive urinary bladder tumours.
|
Huele, Eline H. |
|
|
41 |
1 |
p. 49.e7-49.e12 |
artikel |
20 |
What is the most effective way to ensure that patients successfully undergo germline testing for prostate cancer?
|
Ahlborn, David |
|
|
41 |
1 |
p. 49.e1-49.e6 |
artikel |